OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
February 18, 2021
The deal expands Wavelength’s drug substance manufacturing footprint and its API CDMO business.
February 09, 2021
Model-based approaches and digital analytics are improving flexibility at both the equipment and the manufacturing-line level.
February 02, 2021
CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.
December 23, 2020
The UK company is investing £3 million in new instrumentation and equipment to strengthen its high-throughput screening and translational oncology service offerings.
December 09, 2020
Cytiva is adding process development, media and assay development, and contract development services at its facilities in Korea, Japan, Sweden, and the UK.
Piramal Pharma Solutions invests in expanded potent and non-potent API development and manufacturing at its Riverview, MI facility.
December 02, 2020
CDMOs strive for flexible, adaptable processes and fast tech transfer for manufacturing investigational drug products, including COVID-19 treatments and vaccines.
July 15, 2020
Filling and packaging of primary containers is a crucial piece of COVID-19 vaccine and therapeutic production.
July 08, 2020
The acquisition will give the CDMO additional clinical filling options in Europe, which is expected to come online in 2021.
March 02, 2020
Understanding of scale-up parameters and use of process analytical technology are important to meet demand for larger batch sizes.